MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Akciju saraksts・iRhythm Technologies Inc

iRhythm Technologies Inc

Slēgts

SektorsVeselības aprūpe

116.66 -1.23

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

116.51

Max

117.05

Galvenie mērījumi
By Trading Economics
Ienākumi	11M 5.6M
Pārdošana	16M 209M
Peļņas marža	2.671
Darbinieki	2,400
EBITDA	14M 16M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+80.18% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 30. apr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-955M 3.7B
Iepriekšējā atvēršanas cena	117.89
Iepriekšējā slēgšanas cena	116.66

Ziņu noskaņojums

By Acuity

50%

154 / 349 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

104.78 / 137.91 Atbalsts un pretestība

iRhythm Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. apr. 04:27 UTC

Galvenie ziņu notikumi

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

2026. g. 3. apr. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 3. apr. 18:30 UTC

Galvenie ziņu notikumi

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

2026. g. 3. apr. 18:14 UTC

Tirgus saruna

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

2026. g. 3. apr. 17:50 UTC

Tirgus saruna

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

2026. g. 3. apr. 17:44 UTC

Iegādes, apvienošanās, pārņemšana

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

2026. g. 3. apr. 16:50 UTC

Galvenie ziņu notikumi

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

2026. g. 3. apr. 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 3. apr. 16:12 UTC

Peļņas

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

2026. g. 3. apr. 15:56 UTC

Tirgus saruna

Galvenie ziņu notikumi

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

2026. g. 3. apr. 15:56 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Equities Roundup: Market Talk

2026. g. 3. apr. 15:56 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 3. apr. 15:20 UTC

Galvenie ziņu notikumi

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

2026. g. 3. apr. 15:08 UTC

Iegādes, apvienošanās, pārņemšana

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

2026. g. 3. apr. 14:11 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

2026. g. 3. apr. 12:56 UTC

Tirgus saruna

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

2026. g. 3. apr. 08:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 3. apr. 08:01 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 3. apr. 08:01 UTC

Tirgus saruna

Meituan's Profitability Likely to Improve This Year -- Market Talk

2026. g. 3. apr. 07:45 UTC

Tirgus saruna

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

2026. g. 3. apr. 06:17 UTC

Tirgus saruna

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

2026. g. 3. apr. 06:17 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 3. apr. 04:33 UTC

Tirgus saruna

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

2026. g. 3. apr. 04:33 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 3. apr. 04:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 3. apr. 04:01 UTC

Tirgus saruna

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

2026. g. 3. apr. 02:01 UTC

Tirgus saruna

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

2026. g. 3. apr. 01:59 UTC

Tirgus saruna

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

2026. g. 3. apr. 01:44 UTC

Tirgus saruna

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

2026. g. 3. apr. 01:22 UTC

Tirgus saruna

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Salīdzinājums

Cenas izmaiņa

iRhythm Technologies Inc Prognoze

Cenas mērķis

By TipRanks

80.18% augšup

Prognoze 12 mēnešiem

Vidējais 210.45 USD 80.18%

Augstākais 254 USD

Zemākais 184 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

12 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 12 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

104.78 / 137.91Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Noskaņojums

By Acuity

154 / 349 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.